{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-031311","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.810035+00:00","generated_at":"2026-05-19T08:20:26.378040+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intensity Therapeutics raises ~$1.9M net in $0.30/share public offering for clinical studies","bullets":["Gross proceeds $2,002,500 from 6,675,000 shares at $0.30/share; underwriter exercised over-allotment for 1,001,250 additional shares.","Net proceeds ~$1.9M after underwriting discounts and expenses; offering closed June 13, 2025.","Representative's Warrants for 383,812 shares (5% of offering) issued at $0.375 exercise price, 5-year term.","Proceeds to fund INVINCIBLE-4 data readout (expected H1 2026) and continue INVINCIBLE-3 study maintenance.","ThinkEquity acted as sole book-running manager; shares traded on Nasdaq under INTS."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-031311","json":"https://secwatch.observer/filing/0001628280-25-031311.json","markdown":"https://secwatch.observer/filing/0001628280-25-031311.md","text":"https://secwatch.observer/filing/0001628280-25-031311.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000162828025031311/0001628280-25-031311-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000162828025031311/intensity-20250611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:20:26.378040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}